In another study, ibrutinib-treated HL-1 cells exhibited increased susceptibility to AF due to the inhibition of the PI3K/AKT/mTOR signaling pathway, which enhanced autophagy and led to connexin degradation (Qin et al., 2024). This evidence concerns the gene AKT1 and atrial fibrillation.